Evidence map›Paper›PMID 39056887›Full record

ArticleBiomimetics (Basel, Switzerland)2024

Advanced Kidney Models In Vitro Using the Established Cell Line Renal Proximal Tubular Epithelial/Telomerase Reverse Transcriptase1 for Nephrotoxicity Assays.

Alodia Lacueva-Aparicio, Laura Martínez-Gimeno, Pilar Torcal, Ignacio Ochoa, Ignacio Giménez

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Deciphering the Impact of RAC1-SPTAN1 in ARPKD Cystogenesis Using Multifaceted Models.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alodia Lacueva-AparicioRenal and Cardiovascular Physiopathology (FISIOPREN), Aragon Health Science Institute, 50009 Zaragoza, Spain.ORCID 0000-0003-4970-2460
Laura Martínez-GimenoRenal and Cardiovascular Physiopathology (FISIOPREN), Aragon Health Science Institute, 50009 Zaragoza, Spain.
Pilar TorcalRenal and Cardiovascular Physiopathology (FISIOPREN), Aragon Health Science Institute, 50009 Zaragoza, Spain.
Ignacio OchoaTissue Microenvironment Lab (TME Lab), I3A, University of Zaragoza, 50018 Zaragoza, Spain.
Ignacio GiménezRenal and Cardiovascular Physiopathology (FISIOPREN), Aragon Health Science Institute, 50009 Zaragoza, Spain.ORCID 0000-0002-6043-4869

Funding

Ministerio de Ciencia, Innovación y Universidades DPI2015-65401-C3-1-RMinisterio de Ciencia, Innovación y Universidades RTI2018-099946-B-100
6 · The paper itself

Abstract

Nephrotoxicity stands as one of the most limiting effects in the development and validation of new drugs. The kidney, among the organs evaluated in toxicity assessments, has a higher susceptibility, with nephrotoxic potential frequently evading detection until late in clinical trials. Traditional cell culture, which has been widely used for decades, does not recapitulate the structure and complexity of the native tissue, which can affect cell function, and the response to cytotoxins does not resemble what occurs in the kidney. In the current study, we aimed to address these challenges by creating in vitro kidney models that faithfully biomimic the dynamics of the renal proximal tubule, using the well-established RPTEC/TERT1 cell line. For doing so, two models were developed, one recreating tubule-like structures (2.5D model) and the other using microfluidic technology (kidney-on-a-chip). The 2.5D model allowed tubular structures to be generated in the absence of hydrogels, and the kidney-on-a-chip model allowed shear stress to be applied to the cell culture, which is a physiological stimulus in the renal tissue. After characterization of both models, different nephrotoxic compounds such as cisplatin, tacrolimus, and daunorubicin were used to study cell responses after treatment. The developed models in our study could be a valuable tool for pre-clinical nephrotoxic testing of drugs and new compounds.

Indexed as

3D structureshydrogelin vitro modelskidneykidney-on-a-chipnephrotoxicity

Identifiers

PMID39056887
PMCPMC11275192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.